Schizophrenia Research
Volume 58, Issue 1 , Pages 1-10 , 1 November 2002

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

  • Mohammad M Khan

      Affiliations

    • Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    • ,
  • Denise R Evans

      Affiliations

    • Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    • Medical Research and Mental Health Service Lines, Veterans Affairs Medical Center, Augusta, GA 30910, USA
    • ,
  • Vijayasudha Gunna

      Affiliations

    • Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    • ,
  • Russell E Scheffer

      Affiliations

    • Department of Psychiatry, Southwestern University of Texas, Dallas, USA
    • ,
  • Vinay V Parikh

      Affiliations

    • Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    • ,
  • Sahebarao P Mahadik

      Affiliations

    • Corresponding Author InformationCorresponding author. Medical Research Service (242), Veterans Affairs Medical Center, 5B-103, 1 Freedom Way, Augusta, GA 30904, USA. Tel.: +1-706-733-0188x2490; fax: +1-706-823-3977
    • Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    • Medical Research and Mental Health Service Lines, Veterans Affairs Medical Center, Augusta, GA 30910, USA

Received 1 July 2001 ,Accepted 10 September 2001.

References 

  1. Assies J, Lieverse R, Peter V, Wanders RJA, Dingemans PMJA, Linsezen DH. Significantly reduced level of docosahexaenoic acid and docosapentaenoic acid in erythrocyte membranes from schizophrenia patients compared with a carefully matched control group. Biol. Psychiatry. 2001;49:510–522
  2. Bates C, Horrobin DF, Ells K. Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia. Schizophr. Res. 1992;6:1–7
  3. Bourre JM, Bonneil M, Chaudiere J, Clement M, Dumont O, Durand G, et al.  Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system. Adv. Exp. Med. Biol. 1992;318:211–229
  4. Cadet JL, Lohr JB. Free radicals and the developmental pathophysiology of schizophrenic burnout. Integr. Psychiatry. 1987;5:40–48
  5. Carlson SE, Carver JD, House SG. High fat diets varying in ratio of polyunsaturated to saturated fatty acid and linoleic to linolenic acid: a comparison of rat neural and red cell membrane phospholipids. J. Nutr. 1986;116:718–725
  6. Christinsen O, Christinsen E. Fat consumption and schizophrenia. Acta Psychiatr. Scand. 1988;78:587–591
  7. Connor WE, Lin DS, Neuringer M. Is the docosahexaenoic acid (DHA, 22:6n−3) content of erythrocytes a marker for the DHA content of brain phospholipids?. FASEB J. 1993;7:A152
  8. Evans DR, Mahadik SP, Akin J, Evans W, Jain D. Cell membrane essential fatty acid status in drug-naive first-episode psychotic patients and its relation to outcome. Schizophr. Res. 2001;49:83
  9. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol. Psychiatry. 2000;47:8–21
  10. Glen AIM, Glen EMT, Horrobin DF, Vaddadi KS, Spellman M, Morse-Fisher N, et al. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr. Res. 1994;12:53–61
  11. Jeding I, Evans PJ, Akanmu D, Dexter D, Spencer JD, Aruoma OI, et al. Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochem. Pharmacol. 1995;49:359–365
  12. Horrobin DF. The relationship between schizophrenia and essential fatty acids and eicosanoid metabolism. Prostaglandins, Leukotrienes Essent. Fatty Acids. 1992;46:71–77
  13. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr. Res. 1998;30:193–208
  14. Horrobin DF. The effects of antipsychotic drugs on membrane phospholipids—a possible novel mechanism of action of clozapine. In:  Peet M,  Glen AL,  Horrobin D editor. Phospholipid Spectrum Disorders in Psychiatric. Lancashire, UK: Marius Press; 1999;p. 113–117
  15. Horrobin DF, Glen AIM, Glen EMT, Skinner F. Red cell membrane fatty acids in schizophrenic patients with mainly positive or mainly negative symptoms. Schizophr. Res. 1993;9:221
  16. Horrobin DF, Glen AIM, Vaddadi KS. The membrane hypothesis of schizophrenia. Schizophr. Res. 1994;13:195–208
  17. Innis SM. Essential fatty acids in growth and development. Prog. Lipid Res. 1991;30:39–103
  18. Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C. Erythrocyte membrane phospholipids in psychotic patients. Psychiatry Res. 1993;49:9–95
  19. Kramer Voss H-P, Grimberger JA, Timmerman H, Bast A. The effects of ischemia and recirculation, hypoxia and recovery on antioxidant factors and β-adrenoreceptor density: is the damage in erythrocytes a reflection of brain damage caused by complete cerebral ischemia and by hypoxia?. Biochem. Biophys. Res. Commun. 1987;149:568–575
  20. Lohr JB, Flynn K. Smoking and schizophrenia. Schizophr. Res. 1992;8:93–102
  21. Mahadik SP, Evans D. Essential fatty acids in the treatment of schizophrenia. Drugs Today. 1997;33:5–17
  22. Mahadik SP, Mukherjee S. Free radical pathology and the antioxidant defense in schizophrenia. Schizophr. Res. 1996;19:1–18
  23. Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins, Leukotrienes Essent. Fatty Acids. 1996;55:45–54
  24. Mahadik SP, Mukherjee S, Correnti E, Kelkar HS, Wakade CG, Costa RM, et al. Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr. Res. 1994;13:239–247
  25. Mahadik SP, Mukherjee S, Horrobin D, Jenkins K, Correnti EE, Scheffer RE. Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar and normal controls. Psychiatry Res. 1996;63:133–142
  26. Mahadik SP, Shendarkar NS, Scheffer R, Mukherjee S, Correnti EE. Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls. Prostaglandin, Leukotrienes Essent. Fatty Acids. 1996;55:65–70
  27. Mahadik SP, Mukherjee S, Correnti EE, Scheffer R, Mahadik J. Elevated plasma lipid peroxides at the onset of non-affective psychosis. Biol. Psychiatry. 1998;43:674–679
  28. Mahadik SP, Sitasawad V, Mulchandani M. Membrane peroxidation and the neuropathology of Schizophrenia. In:  Horrobin D,  Glen AL,  Peet M editor. Phospholipid Spectrum Disorders in Psychiatric. Lancashire, UK: Marius Press; 1999;p. 99–111
  29. Mahadik SP, Mulchandani M, Hegde MV, Ranjekar PK. Cultural and socioeconomic differences in dietry intak of essential fatty acids and antioxidants—effects on the outcome. In:  Horrobin D,  Glen AL,  Peet M editor. Phospholipid Spectrum Disorders in Psychiatric. Lancashire, UK: Marius Press; 1999;p. 167–179
  30. Mahadik SP, Evans D, Lal H. Oxidative stress and the role of antioxidant and w−3 essential fatty acid supplementation in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2001;25:463–493
  31. Mahadik SP, Evans DR, Terry A, Hill WD. Neuroprotective action of atypical antipsychotics in schizophrenia: improved cognitive performance and underlying mechanism of action. Schizophr. Res. 2001;49:94
  32. McCreadie RG, MacDonald E, Wiles D, Campbell G, Pateson JR. The Nithsdale Schizophrenia Surveys XIV: plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia and in normal subjects. Br. J. Psychiatry. 1995;170:1–8
  33. Overall JE, Gorham DR. Brief psychiatry rating scale. Psychol. Rep. 1962;10:799–812
  34. Peet M, Laugharne J, Rangarajan N, Renolds GP. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int. Clin. Psychopharmacol. 1993;8:151–153
  35. Peet M, Laugharne J, Mellor JE, Ramchand CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins, Leukotrienes Essent. Fatty Acids. 1996;55:119–122
  36. Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr. Res. 2001;49:243–251
  37. Pettegrew JW, Keshavan MS, Minshew NJ. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex using in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 1991;48:563–568
  38. Reddy R, van Kammen DP, Yao JK. Cigarette smoking and antioxidant status in schizophrenia. Biol. Psychiatry. 1998;43:112S–113S
  39. Reddy R, Yao J. Free radical pathology in schizophrenia: a review. Prostaglandins, Leukotrienes Essent. Fatty Acids. 1996;55:33–43
  40. Rotrosen J, Wolkin A. Phospholipid and prostaglandin hypotheses of schizophrenia. In:  Meltzer HY editors. Psychopharmacology: The Third Generation of Progress. New York: Raven Press; 1987;
  41. Scottish Schizophrenia Research Group . Smoking habits and plasma lipid peroxides and vitamin E in never medicated first-episode schizophrenic patients with schizophrenia. Br. J. Psychiatry. 2000;176:290–293
  42. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A. An in vivo study of the prefrontal cortex of schizophrenic patients at different age of illness via phosphorous magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 1995;52:399–406
  43. Thompson GA. The Regulation of Membrane Lipid Metabolism. 2nd edn.. Boca Raton, FL: CRC Press; 1992;
  44. Vaddadi KS, Courtney P, Gilleard CS, Manku MS, Horrobin DF. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Res. 1989;27:313–323
  45. Wainright PE. Do essential fatty acids play a role in brain and behavioral development?. Neurosci. Biobehav. Rev. 1992;16:193–205
  46. Yao JK. Red blood cell and platelet fatty acid metabolism in schizophrenia. In:  Horrobin D,  Glen AL,  Peet M editor. Phospholipid Spectrum Disorders in Psychiatric. Lancashire, UK: Marius Press; 1999;p. 57–71
  47. Yao JK, van Kammen DP, Welker JA. Red cell membrane dynamics in schizophrenia: II. Fatty acid composition. Schizophr. Res. 1994;13:217–226

PII: S0920-9964(01)00334-6

Schizophrenia Research
Volume 58, Issue 1 , Pages 1-10 , 1 November 2002

Article Tools

* Image Usage & Resolution